Synaptic Glutamate Receptor Trafficking

突触谷氨酸受体贩运

基本信息

  • 批准号:
    8660322
  • 负责人:
  • 金额:
    $ 51.55万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-06-01 至 2017-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The overall goal of my research program is to elucidate the underlying molecular principles that govern the assembly of the postsynaptic component of a synapse. There are three main questions we wish to address. First, what are the sequences of events that occur during synapse formation? Second, how does a synapse maintain a stable anatomical identity? Finally, what is the mechanism whereby activity can induce a change in synapse function? Central to the understanding of synaptic transmission are the glutamate receptors embedded in the postsynaptic density (PSD). To tackle these ambitious goals we use a combination of a number of techniques. The most central to our studies is electrophysiology, since this is the most critical way to measure the functional consequences of our molecular manipulations. This grant is focused on a variety of proteins that act as glutamate receptor auxiliary subunits. While voltage gated ion channels have long been know to be decorated with auxiliary subunits, which control all aspects of trafficking and function, the notio that ligand gated ion channels also associate with auxiliary subunits is quite new. The most studied family of auxiliary subunits is the TARPs, which selectively control the trafficking and function of the AMPAR subtype of glutamate receptor. However, recent studies indicate that other structurally unrelated proteins, such as CNIH2, CKAMP44, and SynDIG1 also serve as AMPAR auxiliary subunits. In addition, NETO-1/2 has been shown to serve a similar role for kainate receptors. In this renewal we will characterize the role of CNIH2 in the brain with the use of conditional knockout mice. Initial results suggest widespread effects of deleting CNIH2. We will also determine the physiological role of TARP ¿-7, an unusual TARP, which sets it apart from the other well characterize TARPs. Understanding the role of SynDIG1 forms the third Aim of this grant. Both overexpression and RNAi in slice culture will be used for these experiments. Finally we will use the CA1 synapse, which normally lacks kainate receptors, as a null to determine the role of NETO-1/2 in trafficking and gating of kainate receptors. It is hoped that these studies will uncover novel roles for glutamate auxiliary proteins in the nervous system. Given the critical role that receptor trafficking plays in synaptic plasticity it is anticipated tht findings from these studies will have direct clinical impact. Indeed, clinically promising AMPAkines exert their effect, in part, by controlling the kinetics of AMPAR gating similar to TARPs.
描述(由申请人提供):我的研究计划的总体目标是阐明控制突触后组件组装的基本分子原理。我们希望解决三个主要问题。首先,突触形成过程中发生的事件顺序是什么?其次,突触如何保持稳定的解剖特性?最后,活动引起突触功能变化的机制是什么?理解突触传递的核心是嵌入突触后密度 (PSD) 中的谷氨酸受体。为了实现这些雄心勃勃的目标,我们结合使用了多种技术。我们研究的最核心是电生理学,因为这是测量分子操作的功能后果的最关键方法。这笔资助主要针对充当谷氨酸受体辅助亚基的多种蛋白质。虽然长期以来人们都知道电压门控离子通道被辅助亚基装饰,辅助亚基控制运输和功能的各个方面,但配体门控离子通道也与辅助亚基相关的概念是相当新的。研究最多的辅助亚基家族是 TARP,它选择性地控制谷氨酸受体 AMPAR 亚型的运输和功能。然而,最近的研究表明,其他结构上不相关的蛋白质,如 CNIH2、CKAMP44 和 SynDIG1 也可充当 AMPAR 辅助亚基。此外,NETO-1/2 已被证明对红藻氨酸受体具有类似的作用。在本次更新中,我们将通过使用来描述 CNIH2 在大脑中的作用 条件敲除小鼠。初步结果表明删除 CNIH2 会产生广泛的影响。我们还将确定 TARP ¿-7 的生理作用,这是一种不寻常的 TARP,这使其与其他具有良好特征的 TARP 区分开来。了解 SynDIG1 的作用构成了本次资助的第三个目标。这些实验将使用切片培养物中的过表达和 RNAi。最后,我们将使用通常缺乏红藻氨酸受体的 CA1 突触作为空值来确定 NETO-1/2 在红藻氨酸受体运输和门控中的作用。希望这些研究能够揭示谷氨酸辅助蛋白在神经系统中的新作用。鉴于受体运输在突触可塑性中发挥的关键作用,预计这些研究的结果将产生直接的临床影响。事实上,临床上有前景的 AMPAkine 发挥作用的部分原因是控制与 TARP 类似的 AMPAR 门控动力学。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROGER A NICOLL其他文献

ROGER A NICOLL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROGER A NICOLL', 18)}}的其他基金

The synaptic cleft and glutamate receptor trafficking
突触间隙和谷氨酸受体运输
  • 批准号:
    10196921
  • 财政年份:
    2018
  • 资助金额:
    $ 51.55万
  • 项目类别:
The synaptic cleft and glutamate receptor trafficking
突触间隙和谷氨酸受体运输
  • 批准号:
    10449275
  • 财政年份:
    2018
  • 资助金额:
    $ 51.55万
  • 项目类别:
2011 Excitatory Synapses and Brain Function GRC
2011 兴奋性突触和脑功能 GRC
  • 批准号:
    8267002
  • 财政年份:
    2011
  • 资助金额:
    $ 51.55万
  • 项目类别:
THE ROLE OF ACTIVITY IN SCULPTING NEURONAL FORM AND FUNCTION
活动在塑造神经元形态和功能中的作用
  • 批准号:
    8361932
  • 财政年份:
    2011
  • 资助金额:
    $ 51.55万
  • 项目类别:
2011 Excitatory Synapses and Brain Function GRC
2011 兴奋性突触和脑功能 GRC
  • 批准号:
    8459583
  • 财政年份:
    2011
  • 资助金额:
    $ 51.55万
  • 项目类别:
2011 Excitatory Synapses and Brain Function GRC
2011 兴奋性突触和脑功能 GRC
  • 批准号:
    8644923
  • 财政年份:
    2011
  • 资助金额:
    $ 51.55万
  • 项目类别:
THE ROLE OF ACTIVITY IN SCULPTING NEURONAL FORM AND FUNCTION
活动在塑造神经元形态和功能中的作用
  • 批准号:
    8169648
  • 财政年份:
    2010
  • 资助金额:
    $ 51.55万
  • 项目类别:
Synaptic Glutamate Receptor Trafficking
突触谷氨酸受体贩运
  • 批准号:
    8529614
  • 财政年份:
    2007
  • 资助金额:
    $ 51.55万
  • 项目类别:
Synaptic Glutamate Receptor Trafficking.
突触谷氨酸受体贩运。
  • 批准号:
    8077998
  • 财政年份:
    2007
  • 资助金额:
    $ 51.55万
  • 项目类别:
Synaptic Glutamate Receptor Trafficking.
突触谷氨酸受体贩运。
  • 批准号:
    7625908
  • 财政年份:
    2007
  • 资助金额:
    $ 51.55万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 51.55万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 51.55万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 51.55万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 51.55万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 51.55万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 51.55万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 51.55万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 51.55万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 51.55万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 51.55万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了